Deal Type: Acquisition
Deal Sub Type: 100% Acquisition
Deal Country: Germany
Deal Status: Rumor
Deal Value: 0.0000 USD
Deal in Brief
Merck KGaA, a chemical, pharmaceutical and life sciences company, intends to sell Allergopharma Joachim Ganzer KG, a manufacturer of diagnostics and prescription drugs for allergen immunotherapy (AIT), according to Bloomberg, citing people familiar with the matter. Reportedly, the transaction is expected to be valued about EUR600 million (USD637.92 million).
This divestment will enable Merck to reduce debt following the acquisition of Sigma-Aldrich Corp for USD17 billion.
Index - Allergies
Index - Germany
Index - House Dust Mite Allergy
Index - Type I Hypersensitivity
Index - Pollen Allergy
Index - Birch Pollen Allergy
Index - Grass Pollen Allergy
(c) 2015 Progressive Media Group Metadata. All rights reserved. Republication or redistribution, including by framing or similar means, is expressly prohibited without prior written consent. Progressive Media Group Metadata shall not be liable for errors or delays in the content, or for any actions taken in reliance thereon., source PDM Deals